A new BIO report outlines the state of early-stage funding for biotechs. Plus, during BIO 2025, legal experts unpacked IRA litigation—here’s what you should know. (761 words, 3 minutes, 48 seconds) ...

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on passage of the One, Big, Beautiful Bill Act (OBBBA): “The ...

We hope you enjoyed the July break. We're back with a look at a new measles record, and what BIO's saying about the One, Big, Beautiful Bill Act, drug patents, and more. (873 words, 4 minutes, 21 ...

BIO hit the American road again, this time to Richmond, VA to meet with Virginia Bio, local entrepreneurs and patient advocates, and a company that's reshoring production of advanced pharmaceutical ...